Description

QL9 (QLSPFPFDL) is a high-affinity alloantigen for the 2C T cell receptor (TCR).–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-immunoregulation–C52H74N10O14—-[1]Speir JA, et al. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity. 1998 May;8(5):553-62.|[2]Bowerman NA, et al. Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides. J Biol Chem. 2009 Nov 20;284(47):32551-61.–159646-83-0–1063.20—-O=C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N1[C@@H](CCC1)C(N[C@@H](CC2=CC=CC=C2)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCC(N)=O)N–Inflammation/Immunology–10 mM in H2O–Others—-Others–Peptides